Dr. Moskowitz will work with the study team to tailor the positive affect intervention for delivery as part of the Phase I work. She will participate in co-investigator meetings and conference calls to assist with trial implementation, interpretation of the results, and manuscript preparation.
|Effective start/end date||9/30/19 → 7/31/23|
- University of Miami (SPC-002231//R01DA049843)
- National Institute on Drug Abuse (SPC-002231//R01DA049843)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.